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Introduction 
 
This paper is a collective account of the First 
International Workshop on The Role and Impact 
of Mathematics in Medicine (RIMM) held at the 
Poincaré Institute in Paris, June 10-12, 2010. 
The workshop brought together mathematicians 
[1-4], physicians [4], mathematical biologists 
[5], biostatisticians [6], modellers [7] and others 
with the goal of understanding how mathemat-
ics and statistics can better impact medicine. 
 
During the meeting, scientific papers were pre-
sented covering a broad range of subjects rang-
ing from mathematical epidemiology to medical 
imaging. Our goal was to "take stock" and reflect 
on our methods, our impact, and the need for 
the mathematical sciences to move from a de-
scriptive to a more prescriptive or predictive role 
in the medical sciences. This paper brings to-
gether contributions on these topics from nine 
of the twenty participants who attended the 
meeting. 
 
Background 
 
The role of mathematics and statistics in the 
clinical and biomedical sciences is ever increas-
ing [8-10]. This is reflected in the growing num-
ber of journals and articles devoted to the sub-
ject [11]. Today there are a number research 
institutions devoted exclusively to the interface 
between mathematics and medicine. The Cen-
tre for Mathematical Medicine in Toronto 
(Canada), the Battelle Center for Mathematical 
Medicine in Columbus, OH, (USA) and the Cen-
tre for Mathematical Medicine and Biology in 
Nottingham (UK) are just three examples in the 
English-speaking world.  
 
The three main goals of theoretical modelling of 
medicine are: (1). elucidation of new under-
standing; (2). prediction of medical/biological 
outcomes    without the need for complex ex-
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periments; (3). derivation of optimal therapeutic 
solutions. 
 
These three goals rely to various degrees on the 
collection and description of data and on the 
construction, optimization and testing of mod-
els. Advances in these areas since the Second 
World War have relied crucially on the advent of 
computers. This has led to the era of computa-
tional mathematics which has greatly extended 
the scope of standard mathematical models. 
Rapid developments in computer science also 
opened new diagnostic frontiers with the devel-
opment of sophisticated imaging software which 
rely heavily on advanced numerical methods 
[12].  
 
The nature of mathematical/medical 
interactions 
 
Prerequisites 
 
The development of well informed mathematical 
models in medicine requires deep knowledge 
and understanding of both mathematics and 
medicine. A small number of workshop partici-
pants had the ideal combination of advanced 
academic training in both areas, e.g. a Ph.D. in 
mathematics and a medical degree. This dual 
training ensures a real commitment to long-
term collaborations and an understanding of 
both languages [13]. It also reassures potential 
collaborators from both fields that the commit-
ment is genuine. It is important to point out that 
training in both areas is currently more the ex-
ception than the rule, but as the influence of 
mathematics in medicine continues to grow this 
situation may change. 
 
Another approach is to train ab initio in an in-
trinsically interdisciplinary field, such as biosta-
tistics or operations research. The former is self-
evident, and in operations research one can 
specialize in applications to medicine. The most 
common situation however is when researchers 
from strictly mathematical or medical back-
grounds come together to solve medical prob-
lems. 
 
The mathematician's challenge  
 
Researchers with a purely mathematical back-
ground need to develop a sustained interest in 
the applications of mathematics to the health 
sciences. Minimal training or self-instruction in 
an area of (bio)medicine compatible with the 
mathematician's interest is essential. In order to 
contribute substantive ideas to the field, years 
of collaboration with a (bio)medical colleague 
are required. Moreover, the specific application 
needs to be carefully chosen. For example, a 
specialist in the theory of partial differential 
equations could find few direct applications of 
his/her expertise in modelling global health 
trends. 
 
The physician's challenge  
 
Practicing medical doctors interested in collabo-
rating with modellers have several hurdles to 
overcome. First their clinical practice leaves 
little time for research. Second, the physician 
needs to be committed to the collaboration 
even when the research may not have immedi-
ate clinical applications. Third, he must be suffi-
ciently well-versed in mathematics. Indeed, doc-
tors are taught basic methods to describe data 
and perform statistical testing. However, model 
building, which is of central importance in 
mathematical medicine, is rarely taught in medi-
cal school. 
 
The meeting of minds and talents 
 
When researchers from the same discipline 
collaborate there may be underlying competi-
tion. When a biologically competent mathemati-
cian and a numerate physician work together, it 
is on the contrary all about complementarity 
and mutual understanding. The physician (or 
more generally life scientist) must understand 
the mathematical nature of his problem and be 
able to communicate it to his mathematical 
counterpart. The mathematician in turn must 
find the right tool to solve the problem and be 
able to explain it to the physician. Ideally the 
results will have clinical applications and the 
physician will develop the self-confidence 
needed to independently use and apply the 
mathematical solution "by the bedside". This 
process can take time. While the busy physician 
gets on with his clinical work the mathematician 
may spend extended periods of time developing 
the solutions and making sure they make sense 
biologically. Such collaboration is rewarding but 
requires dedication and commitment from both 
parties as well as a conviction that mathemati-
cal techniques can help even if there are risks 
involved.  
 
Unfortunately such interdisciplinary collabora-
tions are sometimes viewed with some skepti-
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cism by both disciplines. However this is chang-
ing and there are more and more mechanisms 
in place to facilitate interactions between re-
searchers from different fields. 
 
Mechanisms for interactions 
 
Research centers, universities and governments 
need to facilitate and encourage work that 
takes a project from the modeller's mathemati-
cal "drawing board" to the bedside. This can be 
done by arranging meetings, providing training, 
funding dedicated positions, etc. 
 
Interdisciplinary meetings 
 
Interactions between the mathematical and 
medical sciences occur through interdisciplinary 
conferences and workshops. Conferences in-
volve participants attending talks and engaging 
in personal discussions over breaks. In general, 
however, practitioners in the clinical and bio-
medical areas generally drift towards key con-
ferences in their own areas as do those in the 
mathematical sciences. There are thus few who 
endeavour to present mathematical work at 
biomedical conferences, although this trend is 
changing. Likewise there are few clinicians who 
attend a mathematics-in-medicine conference, 
unless explicitly invited. Thus the conference 
mechanism does not always ensure the maxi-
mum likelihood of interaction between the disci-
plines. 
 
Workshops are generally smaller, in contrast to 
conferences, and rely on the organisers actively 
selecting members from different communities 
who are amenable or open to interdisciplinary 
work. Formats for such meetings include talks 
followed by facilitated periods of discussion. 
These are either directed by the organizers or 
participants are left to freely discuss ideas with 
others in extended discussion/tea breaks? 
Such a mechanism is successful when problem 
areas are clearly identified and the participants, 
particularly those from the life sciences, are 
open to the ideas and insights that mathemati-
cal research can bring. 
 
Given the nature of mathematical research and 
the complexity of problems in the life science 
there exist few forums whereby mathematicians 
are presented with new "open" problems by cli-
nicians and biomedical scientists. One tried and 
tested workshop format in the United Kingdom 
and more recently Canada, is the series of 
Mathematics-in-Medicine Study Groups. 
 
Mathematics-in-Medicine Study Groups 
(MMSGs) 
 
An MMSG workshop is a week-long gathering. 
During the first day clinicians and biomedical 
scientists present their questions/problems to 
an assembled audience of mathematical model-
lers. Following this the problem presenter and 
the mathematicians interested in working on 
their problem spend the rest of the workshop 
brainstorming and working on the problem/
questions. In this way dialogue between the two 
disciplines is focused on a specific problem that 
each is keen to solve. More often than not the 
questions lead to difficult mathematical prob-
lems that are challenging for the mathematical 
modellers. 
 
Such meetings have a successful track record 
of creating new collaborations, projects and 
publications, which are facilitated by further 
follow-up meetings after the main workshop 
(www.maths-in-medicine.org). The format is 
amenable to a wide variation of types of bio-
medical/clinical problems, and often means a 
range of mathematical techniques may be ap-
plied to a problem thanks to the varied mathe-
matical expertise present. 
 
Jennifer Siggers, of the UK MMSG program gave 
the participants an impression of what it is like 
for a mathematician to organise and attend a 
MMSG. To do this she presented a problem pro-
posed at the 2009 meeting on cardiac arrhyth-
mias. Jennifer described the timeline for organ-
ising the group and emphasized the need for 
early planning and continual discussion with the 
clinicians. She described the clinical problem of 
atrial fibrillation and the state of the art in terms 
of treating it. She also briefly described the ap-
proaches that the study group participants had 
tried to use to solve the problem, and the follow-
up work that has been done. 
 
After this the MMSG representatives ran a mini-
MMSG. Marcus Tindall, Alexander Foss and Jen-
nifer Siggers presented two problems, chosen 
for their potential to make some progress in a 
relatively short time. The audience broke into 
two groups and discussed possible approaches 
to tackle the problems. The very short session 
(30 minutes) produced some surprisingly fruitful 
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and insightful discussions. The session con-
cluded with a brief discussion on the role of 
mathematics in medicine, particularly the poten-
tial opportunities and pitfalls, and also a discus-
sion on how to progress further in this area of 
research.  
 
Positive comments on the MMSG presentation 
were received from a number of audience mem-
bers. Many were surprised and impressed that 
it is possible to make any decent progress in 
only one week on a problem for which the par-
ticipants had little or no prior specialist knowl-
edge. 
 
Challenges 
 
Participants did not shy away from the obsta-
cles and difficulties that impede progress in the 
applications of mathematics to medicine. The 
complexity and relevance of mathematical tools 
applied to medicine were identified as two key 
challenges.  
 
Simple vs. complex models 
 
Physicians have difficulty appreciating the role 
of mathematics in their field. At the same time it 
is important to keep them fully involved in the 
entire modelling process (e.g. of model creation) 
and not just consider them as "sources of data 
to feed the models".  
 
Physicians can be discouraged by some mathe-
maticians' "narrowness" of view and reluctance 
to stray much beyond their mathematical com-
fort zone. This can translate into oversimplified 
models that are easy to understand and tracta-
ble but irrelevant. A typical example may be a 
mathematician's propensity to reduce a three-
dimensional problem to one dimension. This 
may simplify his job, but he needs to convince 
the physician that the one-dimensional solution 
is only a first step and/or that it provides at 
least some useful insights into the more realis-
tic problem. 
 
If physicians can be left unconvinced by over-
simplified models, they can, at the other ex-
treme, be overwhelmed by some mathemati-
cians' overly sophisticated models aimed at 
reflecting complex biological or clinical realities. 
Such models are hard to convey to the clinical 
investigators who would ultimately need to 
adopt the resulting technology. Having said this, 
there is a “wow” factor that accompanies com-
plex mathematics, and this can be sufficient to 
have success in publishing the ideas. 
 
To be sure, there is a fine line between develop-
ing an overly simple but tractable model which 
does not mimic reality sufficiently well, and one 
which is overly complex and which cannot be 
properly parameterised or used informatively. In 
any event, as numerical methods improve in 
parallel with computing power, tractability be-
comes less critical. The important issues are 
accuracy, clarity and "relevance by the bedside". 
 
Relevance by the bedside 
 
An unusual characteristic of the workshop is 
that participants came from various (sub)
disciplines and use mathematics in very differ-
ent ways: modelling cardiac rhythms, optimizing 
cancer therapies, fine-tuning medical imaging 
algorithms, or predicting the future number of 
HIV cases are all worthy endeavours. However 
they impact patients in different ways, on differ-
ent time-scales, and in more or less measurable 
ways. This diversity may complicate any narra-
tive concerning success stories "by the bed-
side".  
 
Still, the main reason for using mathematical/
statistical methods in medicine is to improve 
health outcomes and therapies. A model that 
accurately replicates cardiac rhythms or the 
spread of cancer cells is inherently interesting 
as a description of biological processes, even if 
it has no immediate application. It is still vastly 
better if the model is realistic, can be fitted to 
clean data, is predictive and makes a real differ-
ence "by the bedside". As examples, cardiac 
resynchronization therapy and cancer therapy 
have benefited greatly from collaborative efforts 
between the medical and mathematical estab-
lishments. Clinical trials in those and many 
other areas are planned or under way. 
 
Outcomes and their measurement 
 
Tangible outcomes 
 
"Downstream" from the modelling effort, it is 
often the biostatistician or epidemiologist who 
will evaluate a model from initiation of clinical 
testing through to clinical trials and outcome 
studies leading in case of success to clinical 
applications "by the bedside". Indeed, some 
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relatively simple mathematical/statistical con-
cepts have had a major influence on medical 
research and its application in the clinic. These 
include the concept of randomization, which 
revolutionized the way in which new drugs are 
tested, the development of genetic models that 
have led to the identification of numerous 
genes that influence the risk of major diseases, 
and the development of predictive models, 
which are increasingly used by patients, clini-
cians, and healthy members of the public, to 
determine individual risk of disease, or of prog-
nosis among patients with a disease.  
 
Perhaps measurable success by the bedside is 
not the entire story. Outcomes come in various 
forms and may not always be measurable in 
tangible ways. 
 
Intangible trickle-down and other effects  
 
A mathematician's biomedical ignorance can 
have a surprisingly positive effect when extract-
ing the information he needs from a medical 
scientist. Indeed, more and less naive questions 
force the medical scientist to think clearly about 
ideas he may never have articulated before. 
This thinking process will move things along by 
kindling new ideas and getting both sides to 
think together of a problem in converging ways, 
with converging vocabularies. 
 
For example a mathematical epidemiologist 
may query the parameters needed to model the 
usefulness of bed nets to prevent the spread of 
malaria. The medical entomologist will then 
struggle to think of how much/how often mos-
quitoes are found in dwellings, what are the age 
groups of those most likely to be bitten at night, 
etc. This can lead both to think of new control 
strategies such as keeping mosquitoes away 
from dwellings, which may result in alternative 
models with different outcomes. The next time 
the entomologist is in the field he will look at 
things differently and ponder the possibility of 
alternative strategies. The team's report to a 
government or international body (e.g. WHO) 
can influence policymakers and represents a 
trickle-down effect that is intangible and goes 
beyond clear-cut mathematical results on the 
efficiency of bed nets. 
 
Another example is the mathematical modeller 
trying to understand the dynamics of cancer 
cells in a therapeutic rather than purely descrip-
tive perspective. He may challenge an oncolo-
gist into thinking of new ways of fighting tumour 
cells. As an alternative or a complement to at-
tacking them directly with chemicals (cytotoxic 
drugs), the modeller may suggest limiting their 
emergence "at their source" e.g., for leukaemia 
cells, in the bone marrow. In an interactive atti-
tude, the clinician, who usually has already 
thought of this approach, can provide the princi-
ples needed to design optimal strategies at the 
molecular scale. Such strategies, worked out as 
a result of the mathematical-life science interac-
tion, will then be applied in cell cultures, in ani-
mal experiments and finally in clinical trials. This 
movement back and forth between fundamen-
tal research and clinical trials is essential 
(Figure 1).  
 
Conclusion 
 
The workshop participants agreed on a number 
of actions that greatly improve the cross-
disciplinary experience of mathematical model-
lers and medical scientists:  
 
1. Focus on the clinical/biological problem at 
hand, rather than what is either mathematically 
tractable or intellectually interesting to the 
mathematician. 
 
2. Use success stories to convince the medical 
establishment that mathematics and statistics 
can contribute much to medicine.  
 
3. Take data seriously: Results are only as good 
as the data and the methods used to analyze it. 
Figure 1. Flowchart of the collaboration between a 
modeller and clinician (top), leading to clinical trials, 
data analysis (bottom), and clinical applications 
(right). Several trials may be required and further 
iterations necessary after the modeller/clinician 
team receives feedback from the bedside. 
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4. Organize Mathematics-in-Medicine Study 
Groups, which are excellent ways of bringing the 
two sides together.  
 
5. Be committed: optimal results are obtained 
only after years of collaboration, when each 
scientist can make substantive suggestions in 
the partner's discipline. 
 
6. Be an advocate for inter-disciplinarity which 
is essential for scientific advances in medicine.  
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